A chance to make a difference.
Since the disease was only described in 2008, there has been minimal research into developing new cures. Ben has started working on the disease in his lab at Penn and with collaborators at the Children's Hospital of Philadelphia (CHOP), where Lucy and other kids with STXBP1 are treated. He and Lucy's genetic counselor have also begun to motivate work in parallel at top neurodevelopment labs throughout the U.S. and Europe, in partnership with the STXBP1 Foundation. There are several therapeutic strategies that could work, but these require time and money to test!